With a population of over 500 million people, concentrated around major cities, Latin America continues to be a focus area for clinical research.
The region offers many advantages for conducting clinical trials, including:
• Large, heterogeneous population
• Treatment-naive patients
• Highly trained medical staff
• Strong enrolment rates – in some cases 3-5 times greater than US & Western Europe
• Excellent patient retention – approximately 30% less discontinuations versus US & Western Europe
• Well-trained, eager & available Investigators & Clinical Study Staff
• Highly competitive clinical trial costs
• Solid Regulatory framework with reliable processes and predictable timelines in most countries
• Established infrastructure with Clinical Trial experienced Investigators
• Seasonal disease prevalence all year around in some countries allows for extended recruitment advantage